Abcam Liabilities 2024

Abcam Aktienanalyse

What does Abcam do?

Abcam PLC is an internationally operating company specializing in the development, manufacturing, and distribution of antibodies and other reagents for life science research. History: Abcam was founded in 1998 by Jonathan Milner, a biologist and cancer researcher who had experienced using antibodies in research. Recognizing a need for high-quality and reliable reagents in this field, he decided to start his own company. In the years following its founding, Abcam grew rapidly and established itself as one of the leading providers of antibodies. In 2005, the company went public on the London Stock Exchange, raising capital for further expansion. Since then, Abcam has made numerous acquisitions and expanded its product portfolio. Business model: Abcam's business model is based on selling antibodies and other reagents to research institutions, universities, and pharmaceutical companies. The company relies on an extensive network of suppliers and partners to offer a wide range of products. Another important aspect of the business model is the online marketing of Abcam's products. The company operates several websites where customers can browse and order the entire product range. To better understand customer needs, Abcam also conducts regular customer surveys and feedback. Divisions: Abcam offers a wide range of products and services, which are grouped into various divisions: Antibodies: The antibodies division is Abcam's core area, encompassing a variety of monoclonal and polyclonal antibodies for various applications. Proteins: Abcam also offers a wide range of proteins for research in areas such as cancer, neurology, and metabolic diseases. Reagents: In addition to antibodies and proteins, Abcam provides a variety of reagents, including kits for biomarker or enzyme activity determination. Services: Abcam also offers a range of services, including custom antibody development, protein expression, and assay development. Products: Abcam offers a wide range of products for use in various areas of life science research. Some of the most well-known products include: Rabbit monoclonal antibodies: These antibodies are highly specific and sensitive, making them valuable tools in cancer research. Chromatin & nucleic acid purification kits: These kits enable efficient purification of DNA, RNA, and chromatin, which is essential for many genomic and epigenomic applications. ELISA kits: Abcam offers a variety of ELISA kits for the determination of biomarkers and other target molecules. Overall, Abcam is a leading provider of antibodies and other reagents for life science research. Through constant innovation and expansion, the company has successfully grown its business in recent years and is now well-positioned worldwide. Abcam ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Abcam's Liabilities

Abcam's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Abcam's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Abcam's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Abcam's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Abcam’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Abcam stock

What is the level of liabilities of Abcam this year?

Abcam has a debt balance of 330 M GBP this year.

What were the liabilities of Abcam compared to the previous year?

The liabilities of Abcam have increased by 0% dropped compared to the previous year.

What are the consequences of high debt for investors of Abcam?

High liabilities can pose a risk for investors of Abcam, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Abcam?

Low liabilities mean that Abcam has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Abcam affect the company?

An increase in liabilities of Abcam can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Abcam affect the company?

A decrease in the liabilities of Abcam can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Abcam?

Some factors that can influence the liabilities of Abcam include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Abcam so important for investors?

The liabilities of Abcam are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Abcam take to modify the liabilities?

To change its liabilities, Abcam can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Abcam pay?

Over the past 12 months, Abcam paid a dividend of 0.04 GBP . This corresponds to a dividend yield of about 0.29 %. For the coming 12 months, Abcam is expected to pay a dividend of 0.49 GBP.

What is the dividend yield of Abcam?

The current dividend yield of Abcam is 0.29 %.

When does Abcam pay dividends?

Abcam pays a quarterly dividend. This is distributed in the months of December, April, December, April.

How secure is the dividend of Abcam?

Abcam paid dividends every year for the past 4 years.

What is the dividend of Abcam?

For the upcoming 12 months, dividends amounting to 0.49 GBP are expected. This corresponds to a dividend yield of 4 %.

In which sector is Abcam located?

Abcam is assigned to the 'Health' sector.

Wann musste ich die Aktien von Abcam kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Abcam from 4/17/2020 amounting to 0.036 GBP, you needed to have the stock in your portfolio before the ex-date on 3/19/2020.

When did Abcam pay the last dividend?

The last dividend was paid out on 4/17/2020.

What was the dividend of Abcam in the year 2023?

In the year 2023, Abcam distributed 0 GBP as dividends.

In which currency does Abcam pay out the dividend?

The dividends of Abcam are distributed in GBP.